Ptc Therapeutics (PTCT) Debt Ratio (2012 - 2026)

Ptc Therapeutics' Debt Ratio history runs 15 years deep, the most recent figure standing at 0.26 for Q2 2026.

• In Q2 2026, Debt Ratio rose 25.65% year-over-year to 0.26; the TTM figure through Jun 2026 stood at 0.26 (up 25.65% YoY), while the FY2025 annual figure was 0.2, down 37.93% from the prior year.
• Debt Ratio for Q2 2026 stood at 0.26, up from 0.11 in the prior quarter.
• The five-year high for Debt Ratio was 0.54 in Q3 2023, with the low at 0.11 in Q1 2026.
• The 5-year median for Debt Ratio is 0.26 (2023), against an average of 0.28.
• The sharpest annual moves came in 2023 and 2025: Debt Ratio jumped 135.54% in 2023, then tumbled 63.24% in 2025.
• Ptc Therapeutics' Debt Ratio stood at 0.38 in 2022, then plunged by 33.13% to 0.25 in 2023, then gained by 26.22% to 0.32 in 2024, then plunged by 37.93% to 0.2 in 2025, then soared by 32.19% to 0.26 in 2026.
• Business Quant data shows PTCT's Debt Ratio at 0.26 in Q2 2026, 0.11 in Q1 2026, and 0.2 in Q4 2025.